Norwegian Norwegian
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Siste nytt

Roctavian, Hem A Genterapy, Sustains Drop in Bleeding Rates, Phase 3 Data Show

Roctavian, Hem A Genterapy, Sustains Drop in Bleeding Rates, Phase 3 Data Show

Hemofili Nyheter i dag

Tilbake til toppen
Bilde

Please enable the javascript to submit this form

Om

Støttet av utdanningsstipend fra Bayer, BioMarin, Freeline Therapeutics Limited, Pfizer Inc., Shire, Spark Therapeutics og uniQure, Inc.

Essensiell SSL